Arbutus Biopharma targets chronic hepatitis B with Imdusiran, addressing a vast, unmet medical need. Read more on ABUS stock ...

Good morning, everyone. Welcome to our earnings call on our results for the first quarter of 2026. Today's speakers are Clemens Jungsthofel, our CEO; and Christian Hermelingmeier, CFO of Hannover Re.

A potential end to the Iran war doesn't mean the greatest threat to a historically expensive stock market suddenly disappears.

Explore cs case sites, learn how to choose reliable CS2 case opening platforms and understand why rankings rarely tell the ...

Market Roundup Australia CPI (YoY) (Q1): 4.1%, 4.2% forecast, 3.6% previous Australia Trimmed Mean CPI (QoQ) (Q1): 0.8%, 0.9% forecast, 0.9% previous Australia CPI (QoQ) (Q1): 1.4%, 1.4% forecast, ...

In 2026, some of the busiest traders in financial markets may no longer be Wall Street analysts sitting behind multiple ...

Building an agentic AI strategy that pays off - without risking business failure ...

The research arm of Frankfurt-based Deutsche Bank sees a “super” El Niño developing from this month until July, threatening to further accelerate ...

There's a lot going on with The Way Home Season 4 Episode 3, and we attempt to piece it all together in our review.

UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.48244. Operator: Good day, and thank you for standing by. Welcome to the UroGen Pharma Q1 2026 Results ...

The gold market has experienced unpredictable developments in the first four months of 2026, with prices plunging sharply after hitting a peak in late January.

Historically, May has been a relatively lackluster month for equities. Since 1950, the S&P 500 has delivered an average return of just 0.4% and finished higher 62% of the time, ranking as the ...